BeStock  
Stocks › ADPT

Adaptive Biotechnologies ADPT

US equityMarket cap rank #2143
$29.84 +$1.49 (+5.26%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $30.00 +0.54%
Open$28.57
Prev close$28.35
Day range$28.16 – $29.86
Volume1.43M
Market cap$4.76B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$71.55M+21.5% YoY
Operating profit-$15.77M+37.0% YoY
Net profit-$39.94M-56.1% YoY
Diluted EPS-$0.25-47.1% YoY

Revenue, last 8 quarters

$46.4MSep '24$47.5MDec '24$52.4MMar '25$58.9MJun '25$94.0MSep '25$71.7MDec '25$70.9MMar '26$71.6MJun '26

Net profit, last 8 quarters

$-32.1MSep '24$-33.7MDec '24$-29.8MMar '25$-25.6MJun '25$9.5MSep '25$-13.6MDec '25$-20.0MMar '26$-39.9MJun '26

Diluted EPS by quarter

-0.22Sep '24-0.23Dec '24-0.20Mar '25-0.17Jun '250.06Sep '25-0.09Dec '25-0.13Mar '26-0.25Jun '26

Annual revenue

$98.4MFY20$154.3MFY21$185.3MFY22$170.3MFY23$179.0MFY24$277.0MFY25

Profitability & balance sheet

Gross margin75.6%
Operating margin-12.2%
Net margin-20.7%
Return on equity-39.6%
Return on assets-11.2%
Return on invested capital-14.9%
Current ratio4.79
Liabilities / assets76.5%
Cash & investments$344.26M
Total debt$401.68M
Net cash (debt)-$57.42M

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Minimal Residual Disease (MRD)$93.66M 84.1%
  • Immune Medicine$17.66M 15.9%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $71.55M $70.87M $276.98M $71.68M $93.97M
Total Operating Revenue $71.55M $70.87M $276.98M $71.68M $93.97M
Cost of Revenue $20.17M $18.71M $71.36M $18.22M $18.16M
Gross Profit $51.39M $52.17M $205.62M $53.46M $75.82M
Operating Expense $67.16M $71.37M $262.74M $66.23M $65.53M
Selling and Admin Expenses $47.58M $47.33M $167.27M $44.04M $41.43M
-Selling & Marketing Expense $26.41M $26.35M $94.57M $24.48M $23.47M
-General & Admin Expense $21.17M $20.98M $72.70M $19.56M $17.96M
Research & Development $19.15M $23.62M $93.77M $21.76M $23.67M
Depreciation & Amortization & Depletion $423,000.00 $419,000.00 $1.70M $429,000.00 $428,000.00
-Depreciation & Amortization $423,000.00 $419,000.00 $1.70M $429,000.00 $428,000.00
Operating Profit -$15.77M -$19.21M -$57.12M -$12.77M $10.29M
Net Non-Operating Interest Income (Expense) -$438,000.00 -$809,000.00 -$2.33M -$806,000.00 -$745,000.00
Non-Operating Interest Income $2.26M $2.08M $9.44M $2.15M $2.23M
Non-Operating Interest Expense $2.69M $2.89M $11.78M $2.95M $2.97M
Other Income (Expense) -$23.73M – – – –
Special Income (Charges) -$23.73M – $0.00 $0.00 $0.00
-Less:Other Special Charges $23.73M – – – –
Pretax Profit -$39.94M -$20.02M -$59.46M -$13.58M $9.55M
Net Profit -$39.94M -$20.02M -$59.46M -$13.58M $9.55M
Profit from Continuing Operations -$39.94M -$20.02M -$59.46M -$13.58M $9.55M
Minority Interests -$153,000.00 $18,000.00 $42,000.00 $0.00 -$1,000.00
Net Income to Parent Company -$39.79M -$20.03M -$59.50M -$13.58M $9.55M
Net Income to Common Stockholders -$39.79M -$20.03M -$59.50M -$13.58M $9.55M
Basic EPS -$0.25 -$0.13 -$0.39 -$0.09 $0.06
Diluted EPS -$0.25 -$0.13 -$0.39 -$0.09 $0.06
-Less:Impairment of Capital Assets – – $0.00 $0.00 $0.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Total Assets $640.68M $505.94M $512.74M $490.61M $496.64M
Total Current Assets $420.56M $291.81M $300.19M $281.44M $261.86M
Cash and Cash Equivalents & Short-Term Investments $344.26M $218.33M $226.98M $212.77M $197.87M
-Cash and Cash Equivalents $169.87M $77.58M $70.50M $55.03M $43.16M
-Short Term Investments $174.38M $140.75M $156.49M $157.74M $154.71M
Receivables $49.51M $48.32M $50.37M $44.82M $44.29M
-Accounts Receivable $49.51M $48.32M $50.37M $44.82M $44.29M
Inventory $10.50M $11.21M $9.82M $9.93M $8.40M
Other Current Assets $16.30M $13.95M $13.02M $13.91M $11.30M
Total Non-Current Assets $220.12M $214.14M $212.55M $209.18M $234.78M
Net PPE $68.57M $71.02M $74.72M $79.49M $84.39M
-Gross PPE $68.57M $71.02M $170.51M $79.49M $84.39M
Investments and Advances $27.48M $18.89M $13.23M $4.04M $24.10M
-Available for Sale Securities $27.48M $18.89M $13.23M $4.04M $24.10M
Goodwill and Other Intangible Assets $119.86M $120.28M $120.70M $121.13M $121.56M
-Goodwill $118.97M $118.97M $118.97M $118.97M $118.97M
-Other Intangible Assets $884,000.00 $1.31M $1.73M $2.16M $2.58M
Other Non-Current Assets $4.21M $3.95M $3.90M $4.53M $4.73M
Total Liabilities $490.02M $281.70M $287.74M $286.36M $317.10M
Total Current Liabilities $87.71M $87.01M $89.92M $83.36M $92.14M
Payables $5.24M $9.62M $7.01M $10.27M $6.91M
-Accounts Payable $5.24M $9.62M $6.47M $10.27M $6.91M
Current Accrued Expenses $10.65M $7.47M $7.16M $7.21M $7.21M
Short-Term Debt and Capital Lease Obligation $8.82M $8.51M $8.92M $9.44M $9.96M
-Current Capital Lease Obligation $8.82M $8.51M $8.92M $9.44M $9.96M
Current Deferred Liabilities $53.26M $49.40M $45.19M $41.34M $55.30M
Total Non-Current Liabilities $402.30M $194.69M $197.82M $203.00M $224.96M
Long Term Debt and Capital Lease Obligation $401.68M $69.12M $70.23M $72.36M $74.41M
-Long Term Debt $334.88M – – – –
-Long Term Capital Lease Obligation $66.80M $69.12M $70.23M $72.36M $74.41M
Non-Current Deferred Liabilities $608,000.00 $807,000.00 $1.01M $1.21M $20.03M
Other Non-Current Liabilities $20,000.00 $124.77M $126.59M $129.43M $130.52M
Total Equity $150.66M $224.24M $225.00M $204.25M $179.54M
Stockholders' Equity $142.91M $216.34M $218.79M $204.44M $179.72M
Capital Stock $16,000.00 $16,000.00 $15,000.00 $15,000.00 $15,000.00
-Common Stock $16,000.00 $16,000.00 $15,000.00 $15,000.00 $15,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.57B $1.60B $1.58B $1.55B $1.54B
Retained Earnings -$1.42B -$1.38B -$1.36B -$1.35B -$1.36B
Gains/Losses Not Affecting Retained Earnings -$212,000.00 -$28,000.00 $253,000.00 $211,000.00 $73,000.00
Minority Interests $7.75M $7.90M $6.21M -$182,000.00 -$181,000.00
Other Current Liabilities – $5.80M $4.64M $2.43M $3.07M
-Accumulated Depreciation – – -$95.79M – –
-Total Tax Payable – – $541,000.00 – –

Discussion

No comments yet — be the first to weigh in on ADPT.

Leave a comment

Scroll to Top